Loading...
Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience
INTRODUCTION: The latest guidelines of the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) to test Human Epidermal Growth Factor Receptor 2 (HER2) in breast cancer after being revised in 2008 underwent a second modification in October 2013. The modification includes...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608798/ https://ncbi.nlm.nih.gov/pubmed/26473483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0140652 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|